Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues Second Quarter Financial Results
September 15, 2021 08:30 ET | Polydex Pharmaceuticals Limited
TORONTO, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC Pink: POLXF) (the “Company”) reports financial results for the second quarter of fiscal 2022, the period ended July...
22157.jpg
Worldwide Dextran Sulfate Sodium (DSS) Industry to 2026 - by Manufacturers, Regions, Technology, Application and Product Type
August 31, 2021 06:28 ET | Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Dextran Sulfate Sodium (DSS) Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues First Quarter Financial Results
June 15, 2021 08:45 ET | Polydex Pharmaceuticals Limited
TORONTO, June 15, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports financial results for the first quarter of fiscal 2022, the period ended April...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues Year End Financial Results
April 30, 2021 09:25 ET | Polydex Pharmaceuticals Limited
TORONTO, April 30, 2021 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets: POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2021. All figures are...
22157.jpg
Insights on the IV and Oral Iron Drugs Global Market to 2026 - by Route of Administration, Application, Patient Group, Distribution and Geography
February 19, 2021 05:58 ET | Research and Markets
Dublin, Feb. 19, 2021 (GLOBE NEWSWIRE) -- The "IV and Oral Iron Drugs Market - Global Outlook and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. In-depth Analysis...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues Third Quarter Financial Results
December 15, 2020 09:00 ET | Polydex Pharmaceuticals Limited
TORONTO, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the third quarter of fiscal 2021, the period...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues Second Quarter Financial Results
September 15, 2020 11:30 ET | Polydex Pharmaceuticals Limited
TORONTO, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the second quarter of fiscal 2021, the...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues First Quarter Financial Results
June 15, 2020 09:00 ET | Polydex Pharmaceuticals Limited
TORONTO, June 15, 2020 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the first quarter of fiscal 2021, the period...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Provides Year End Financial Report Closing the Year With A Strong Cash Position and Low Debt
April 30, 2020 09:00 ET | Polydex Pharmaceuticals Limited
TORONTO, April 30, 2020 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (OTC/Pink:POLXF) (the “Company”) reports financial results for its fiscal year ended January 31, 2020. All figures are...
Polydex Pharmaceuticals Limited Logo
Polydex Pharmaceuticals Issues Second Quarter Financial Results
September 16, 2019 09:00 ET | Polydex Pharmaceuticals Limited
TORONTO, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) is pleased to report financial results for the second  quarter of fiscal 2020, the...